want to rid yourself of your autoimmune disease and fecuce your vulnerability yo corona virus
ez
see also pubmedorg faustman dl uspto.gov. inventor search faustman pubmed.org ridtori+ bcg
esnt to mske the vloens in the gas madks sweat to death? trach your children the fundamrntsls of the japanese subway sarin caper
Curr Opin Immunol. 2018 Dec;55:89-96. doi: 10.1016/j.coi.2018.09.016. Epub 2018 Nov 15.
Bridging the gap between vaccination with Bacille Calmette-Guérin (BCG) and immunological tolerance: the cases of type 1 diabetes and multiple sclerosis.
Abstract
At the end of past century, when the prevailing view was that treatment of autoimmunity required immune suppression, experimental evidence suggested an approach of immune-stimulation such as with the BCG vaccine in type 1 diabetes (T1D) and multiple sclerosis (MS). Translating these basic studies into clinical trials, we showed the following: BCG harnessed the immune system to 'permanently' lower blood sugar, even in advanced T1D; BCG appeared to delay the disease progression in early MS; the effects were long-lasting (years after vaccination) in both diseases. The recently demonstrated capacity of BCG to boost glycolysis may explain both the improvement of metabolic indexes in T1D, and the more efficient generation of inducible regulatory T cells, which counteract the autoimmune attack and foster repair mechanisms.
Coronavirus ‘exit strategy’ could be months — or years — away with little study and much puffery. yale has probably replaced or supplemented its classes on the black death w humans that fear much & study less
Enlarge Image
Medical personnel perform coronavirus tests on a motorist at a drive-through testing site.AP
Sign up for our special edition newsletter to get a daily update on the coronavirus pandemic.
Learn to love your lockdown, experts say — because it may not end anytime soon.
The coronavirus threat will continue to loom for months or even years before mass vaccinations or natural immunities will eliminate its dangers, according to the BBC.
“We do have a big problem in what the exit strategy is and how we get out of this,” said epidemiologist Mark Woolhouse of the University of Edinburgh. “No country has an exit strategy.”
President Trump has refused to say how long policies of social distancing will have to last.
“We’ll have to see what the results are at the end of 14 days, let’s say,” he said Friday — one week after launching the national strategy to tamp down the spread of the virus.
British Prime Minister Boris Johnson has said that the UK can “turn the tide” after three months of school closures and mass-gathering bans.
But neither timeline may be enough.
While a vaccine against the novel virus is already being tested — on the fastest vaccine development path ever seen, US officials have boasted — it will take at least 12 to 18 months to determine whether it works and to ensure it carries no dangerous side effects.
Healthy people who are exposed to the virus may build up natural immunities to it, experts say. Once enough of them have done so, pandemic spread in the rest of the population will no longer be possible.
But that process could take up to two years — and will inevitably cause significant illness and death along the way.
The best hope for a quick solution will be the development of new treatment methods that would keep coronavirus patients from developing deadly complications, like pneumonia. Several drugs are already being tested.
A final option: “Permanent changes in our behavior that allow us to keep transmission rates low,” Woolhouse said.
That could include strict policies of testing and quarantine for anyone who comes down with COVID-19 — or even long-term bans on large gatherings.
No comments:
Post a Comment